Abstract:Radiotherapy is one common curative treatment choice for esophageal squamous cell carcinoma (ESCC). Increasing evidences have demonstrated that long noncoding RNAs (LncRNAs) were closely associated with tumor initiation and progression. Whether LncRNAs were involved in regulating tumor radioresponse and tumor microenvironment influenced LncRNAs expressions in cancer cells have as yet remained unknown. Our study aimed to investigate the effect of LncRNAs on the radioresistance and the mechanisms involved in ESCC. By qRT-PCR analysis, the mRNA levels of 94 cancer-related LncRNAs in LncRNAs & disease database were examined in tumor tissues of ESCC patients (n=23) and their matched adjacent normal tissues (n=23). The effect of LncRNAs on tumor radioresistance was investigated in vitro by clonogenic survival assay, detection of DNA double-strand breaks (DSBs) and by flow cytometry analysis on cell apoptosis. By lentivirus transduction, the expression of objective LncRNA was stably down-regulated. By establishment of xenograft tumor models in BALB/c nude mice, the effect of LncRNAs on radioresistance was investigated in vivo. By primary culture, CAFs (cancer-associated fibroblasts), a main component of tumor microenvironment, had been successfully isolated from tumor tissues of two ESCC patients, respectively. By co-culture of CAFs and ESCC cells, the effect of CAFs on LncRNAs expressions in cancer cells was investigated. DNM3OS among the 94 cancer-related LncRNAs was found to be highly expressed with an average 6.43 fold increase in tumor tissues of ESCC patients compared with in matched adjacent normal tissues. In ESCC cells KYSE-30, KYSE-140, KYSE-150, KYSE-180 and KYSE-450, the expressions of DNM3OS were also significantly higher than that in normal esophageal epithelial cell HFL-1, and further increased following 4 Gy of radiation. Down-regulation of DNM3OS expression significantly radiosensitized KYSE-30 and KYSE-140, inducing decreased clonogenic survival and increased DSBs and cell apoptosis by inhibiting DNA damage repair response. Stable down-regulation of DNM3OS expression in KYSE-30 and KYSE-140 also significantly improved the radiosensitivity of xenograft tumor models. Furthermore, we found CAFs were capable of promoting DNM3OS expression in ESCC cells with an approximately 15 fold increase in a TNFSF4 (Tumor Necrosis Factor Superfamily, Member 4)-dependent manner. Co-culture of ESCC cells and CAFs significantly enhanced the radioresistance as a result of increased DNM3OS expression. Our study highlighted CAFs-promoted DNM3OS in ESCC cells as an attractive target to improve the radiosensitivity.

Xrcc3 is A Promising Target to Improve the Radiotherapy Effect of Esophageal Squamous Cell Carcinoma

Effects and Underlying Mechanisms of Homologous Recombina-Tion-associated Protein XRCC3 on Esophageal Squamous-Cell Carci-Noma Radiotherapy Response

NRIP3 Upregulation Confers Resistance to Chemoradiotherapy in ESCC Via RTF2 Removal by Accelerating Ubiquitination and Degradation of RTF2

Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells.

Analysis of correlation between protein expression of XRCC1 and ERCC1 with efficacy of concurrent radiochemotherapy and the prognosis of patients with esophageal aquamous cell carcinoma

miR-4443 promotes radiation resistance of esophageal squamous cell carcinoma via targeting PTPRJ

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma

The enhancement of radiosensitivity in human esophageal squamous cell carcinoma cells by zoledronic acid and its potential mechanism

Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma

CAFs-Secreted CXCL1 Mediated Radioresistance by Regulating DNA Damage Response in an ROS-Dependent Manner in Esophageal Squamous Cell Carcinoma

Xrcc2 As A Predictive Biomarker for Radioresistance in Locally Advanced Rectal Cancer Patients Undergoing Preoperative Radiotherapy

Implication of CCNG1 in radiosensitivity via the Wnt/β-catenin pathway in esophageal squamous cells

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma

CAFs-Promoted LncRNA DNM3OS Conferred Radioresistance by Regulating DNA Damage Response in a TNFSF4-Dependent Manner in Esophageal Squamous Cell Carcinoma

EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway

Inhibition of Human Positive Cofactor 4 Radiosensitizes Human Esophageal Squmaous Cell Carcinoma Cells by Suppressing XLF-mediated Nonhomologous End Joining

PI3Kα Inhibitors Sensitize Esophageal Squamous Cell Carcinoma to Radiation by Abrogating Survival Signals in Tumor Cells and Tumor Microenvironment.

LncRNA DGCR5 Silencing Enhances the Radio-Sensitivity of Human Esophageal Squamous Cell Carcinoma via Negatively Regulating the Warburg Effect

ΔNp63α promotes radioresistance in esophageal squamous cell carcinoma through the PLEC-KEAP1-NRF2 feedback loop